Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.

Featured Stories

Drug Pricing Battles To Watch In 2026 No Photo Available

With drugmakers already pushing back on drug affordability programs and policies, Law360 looks at the year ahead for litigation focuse... (more story)

SnapChat, Pork And Big Prosecutions: Trials To Watch In 2026 No Photo Available

The coming year is set to bring high-profile trials, including in the criminal case against SCOTUSblog co-founder Tom Goldstein, as we... (more story)

Pennsylvania Cases To Watch In 2026 No Photo Available

As winter's chill rings in the new year, several high-profile cases are set to heat up Pennsylvania's dockets in 2026, including disci... (more story)